ACMJ
Anatolian Current Medical Journal

Anatolian Current Medical Journal (ACMJ) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

eISSN: 2718-0115
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Clinical profiles in pediatric systemic lupus erythematosus: a retrospective study
Abstract
Aims: This study aimed to analyse clinical and laboratory findings, prognosis, and survival of systemic lupus erythematosus (SLE) patients, differentiating according to gender, pubertal status, and renal involvement.
Methods: Ninety-six pediatric SLE patients, diagnosed using ACR criteria, were retrospectively analyzed. Inclusion criteria comprised age under 18, meeting at least four ACR criteria, and six months of monitoring. Data encompassed demographics, symptoms, diagnosis, organ involvement, autoantibodies, treatment, prognosis, and survival. Categorization was based on gender and pubertal status. Renal biopsies followed WHO-ISN classification, with asymptomatic findings termed “silent lupus nephritis.” Biopsied patients were divided into proliferative and non-proliferative lupus nephritis categories, excluding irreversible damage cases. Outcomes studied included remission, relapse, end-stage renal failure, and mortality.
Results: Among 96 participants, females constituted 82.3%, males 17.7%, resulting in a female-to-male ratio of 4.6:1. Mean age at diagnosis was 11.9 years, with 37 prepubertal (38.5%) and 59 pubertal (61.5%) cases. Oral-nasal ulcers (p=0.01) were more prevalent in males related to system involvement. Nephrotic syndrome prevalence increased from 21.6% in prepubertal to 44.1% in pubertal cases (p=0.025). Positive Anticardiolipin IgM antibodies decreased from 56.2% in prepubertal to 25.9% in pubertal cases (p=0.047). Type IV lupus nephritis was predominant, followed by Type II, in prepubertal and pubertal groups and both genders. Proliferative lupus nephritis showed higher rates of renal involvement (95.7% vs. 65.6%), nephrotic syndrome (46.8% vs. 21.9%), proteinuria (89.4% vs. 62.5%), hematuria (57.4% vs. 28.1%), elevated creatinine (43.5% vs. 9.7%), and low albumin (67.4% vs. 23.3%). Cases with proliferative lupus nephritis had higher neuropsychiatric involvement (36.2% vs. 12.5%), seizures (25.5% vs. 3.1%, p=0.008), and increased hemolytic anemia rates (78.7% vs. 56.2%, p=0.033). Thirteen had silent lupus nephritis, revealing various types through biopsy. All reported deaths occurred within the first five years, resulting in stable 91% survival rates at 5, 10, and 15 years.
Conclusion: This study provides insights into the clinical, prognostic, and survival characteristics of pediatric systemic lupus erythematosus (SLE), revealing notable patterns related to gender, pubertal development, and renal involvement. There is an association between proliferative lupus nephritis and renal involvement, nephrotic syndrome, and neuropsychiatric symptoms. Significantly, silent lupus nephritis highlights the complex renal implications, necessitating diligent surveillance for prompt intervention.

Keywords : Pediatric systemic lupus erythematosus (SLE), gender, pubertal status, renal involvement, proliferative lupus nephritis, silent lupus nephritis

Download Article


1. Bernatsky S, Joseph L, Pineau CA, Tamblyn R, FeldmanDE, Clarke AE. A population-based assessment of systemiclupus erythematosus incidence and prevalence—results andimplications of using administrative data for epidemiologicalstudies. Rheumatol. 2007;46(12):1814-1818.
2. Cassidy JT. Juvenile idiopathic arthritis. In Cassidy JT, Petty R.E. 2005.
3. Salmon J, Pricop L, D’Agati V. Immunopathology of systemiclupus erythematosus. In: Hochberg M, Silman AK, Smolen J,et al. (eds.). Rheumatology. 6th ed. Elsevier Mosby, St Louis2015:1052-1067.
4. Zhu J, Wu F, Huang X. Age-related differences in the clinicalcharacteristics of systemic lupus erythematosus in children.Rheumatol Int. 2013;33(1):111-115.
5. Hochberg MC. Updating the American College ofRheumatology revised criteria for the classification of systemiclupus erythematosus. Arthritis Rheumatism. 1997;40(9):1725.doi:10.1002/art.1780400928
6. Marshall WA, Tanner JM. Variations in pattern of pubertalchanges in girls. Arch Dis Child. 1969;44(235):291-303.
7. Churg J. Renal disease. Classific Atlas Glomerular Dis. 1995:155.
8. Singh S, Saxena R, Palmer BF. Lupus nephritis. Am J Med Sci.2009;337(6):451-460.
9. Mina R, Von Scheven E, Ardoin SP, et al. Consensus treatmentplans for induction therapy of newly diagnosed proliferativelupus nephritis in juvenile systemic lupus erythematosus.Arthritis Care Res. 2012;64(3):375-383.
10. Cattran DC, Feehally J, Terence Cook H, et al. Kidney disease:improving global outcomes (KDIGO) glomerular diseases workgroup. KDIGO 2021 clinical practice guideline for the managementof glomerular diseases. Kidney Int. 2021;100(4S):139-274.
11. Lehman TJA, McCurdy DK, Bernstein BH, King KK, Hanson V.Systemic lupus erythematosus in the first decade of life. Pediatr.1989;83(2):235-239.
12. Smith CD, Cyr M. The history of lupus erythematosus: fromHippocrates to Osler. Rheumatic Dis Clin North Am. 1988;14(1):1-14.
13. Pluchinotta FR, Schiavo B, Vittadello F, Martini G, PerilongoG, Zulian F. Distinctive clinical features of pediatric systemiclupus erythematosus in three different age classes. Lupus.2007;16(8):550-555.
14. Bader-Meunier B, Armengaud JB, Haddad E, et al. Initialpresentation of childhood-onset systemic lupus erythematosus: aFrench multicenter study. J Pediatr. 2005;146(5):648-653.
15. Walker SE. Estrogen and autoimmune disease. Clin Rev AllergyImmunol. 2011;40(1):60-65.
16. Thabet Y, Mankaï A, Achour A, Sakly W, Trabelsi A, Harbi A.Systemic lupus erythematosus in children: a study about 37Tunisian cases. J Clin Cell Immunol. 2014;5(192):2.
17. Lukic A, Lukic IK, Malcic I, et al. Childhood-onset systemiclupus erythematosus in Croatia: demographic, clinical andlaboratory features, and factors influencing time to diagnosis.Clin Experimen Rheumatol. 2013;31(5):803-812.
18. Abdwani R, Abdalla E, Al-Zakwani I. Unique characteristics ofprepubertal onset systemic lupus erythematosus. Int J Pediatr.2019;2019:9537065.
19. Qiu S, Zhang H, Yu S, et al. Clinical manifestations, prognosis,and treat-to-target assessment of pediatric lupus nephritis. PediatrNephrol. 2022;37(2):367-376. doi:10.1007/s00467-021-05164-y
20. Nandi M, Mondal R. Renal involvement in childhood lupus:a study from Kolkata, India. Saudi J Kidney Dis Transplant.2012;23(4):871.
21. Chiang LL, Lin YT, Chan HY, Chiang BL. Differentialmanifestations of prepubescent, pubescent and postpubescentpediatric patients with systemic lupus erythematosus: aretrospective study of 96 Chinese children and adolescents.Pediatr Rheumatol. 2012;10(1):1-9.
22. Perfumo F, Martini A. Lupus nephritis in children. Lupus.2005;14(1):83-88.
23. Khandelwal P, Govindarajan S, Bagga A. Management andoutcomes in children with lupus nephritis in the developingcountries. Pediatr Nephrol. 2023;38(4):987-1000. doi:10.1007/s00467-022-05769-x
24. Boussetta A, Louati D, Jellouli M, et al. Lupus nephritis inTunisian children: predictive factors of poor outcomes. Saudi JKidney Dis Transplant. 2022;33(3):440-448. doi:10.4103/1319-2442.385968
25. Rianthavorn P, Buddhasri A. Long-term renal outcomes ofchildhood-onset global and segmental diffuse proliferative lupusnephritis. Pediatr Nephrol. 2015;30(11):1969-1976.
26. Hui-Yuen JS, Imundo LF, Avitabile C, Kahn PJ, Eichenfield AH,Levy DM. Early versus later onset childhood-onset systemiclupus erythematosus: clinical features, treatment and outcome.Lupus. 2011;20(9):952-959.
27. Huang JL, Yeh KW, Yao TC, et al. Pediatric lupus in Asia. Lupus.2010;19(12):1414-1418.
28. Hiraki LT, Benseler SM, Tyrrell PN, Hebert D, Harvey E,Silverman ED. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: alongitudinal study. J Pediatr. 2008;152(4):550-556.
29. Wu J-Y, Yeh K-W, Huang J-L. Early predictors of outcomesin pediatric lupus nephritis: focus on proliferative lesions.In: Seminars in Arthritis and Rheumatism. Vol 43. Elsevier;2014:513-520.
30. Duran E, Tolga Y, Taghiyeva A, Bilgin E, Ar M, ErtenliAI. Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis : singlecentre, cross-disciplinary experience. Lupus. 2022;31(9):1147-1156. doi:10.1177/09612033221106305
31. Mannemuddhu SS, Shoemaker LR, Bozorgmehri S, et al. Doeskidney biopsy in pediatric lupus patients “complement” themanagement and outcomes of silent lupus nephritis? lessonslearned from a pediatric cohort. Pediatr Nephrol. 2023;38(8):2669-2678. doi:10.1007/s00467-022-05859-w
32. González-Crespo MR, López-Fernández JI, Usera G, Poveda MJ,Gómez-Reino JJ. Outcome of silent lupus nephritis. In: Seminarsin Arthritis and Rheumatism. Vol 26. Elsevier; 1996:468-476.
33. Samanta M, Nandi M, Mondal R, et al. Childhood lupusnephritis: 12 years of experience from a developing country’sperspective. Eur J Rheumatol. 2017;4(3):178-183. doi:10.5152/eurjrheum.2017.16117
34. Listiyono F, Murni I, Sumadiono S, Satria C. Predictors ofmortality in children with systemic lupus erythematosus. PaediatrIndonesiana. 2019;59(1):1-6. doi:10.14238/pi59.1.2019.1-6.
Article available in :
Volume 6, Issue 1, 2024
Page : 29-37
https://doi.org/10.38053/acmj.1379422
Article Information
Received : 22 Eki 2023
Accepted : 06 Ara 2023
Published : 15 Oca 2024
Corresponding Author :

Aylin Kılınç Uğurlu: Department of Pediatrics, Dr. Sami Ulus Maternity Child Health and Diseases Training and Research Hospital, Ankara, Turkiye

[email protected]
Citation : Kılınç Uğurlu A, Gülfem Özlü S, Kargın Çakıcı E, et al. Clinical profiles in pediatric systemic lupus erythematosus: a retrospective study. Anatolian Curr Med J. 2024;6(1):29-37.

Read: 152
Cited: 0
Download : 105
_Footer